$BBLR
Bubblr Inc. Stock $bblr

$bblr Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000149315224045296 Filed on November 14, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$1.415K	$1.151K
YoY Change		22.94%
Cost Of Revenue		$140.00
YoY Change
Gross Profit		$1.275K	$1.151K
YoY Change		10.77%
Gross Profit Margin		90.11%	100.0%
Selling, General & Admin		$340.6K	$1.109M
YoY Change		-69.29%	1358.73%
% of Gross Profit		26712.94%	96364.81%
Research & Development		$53.89K	$59.89K
YoY Change		-10.02%	12.72%
% of Gross Profit		4226.35%	5203.21%
Depreciation & Amortization		$1.179K	$176.8K
YoY Change		-99.33%
% of Gross Profit		92.47%	15364.03%
Operating Expenses		$471.9K	$1.237M
YoY Change		-61.86%	142.57%
Operating Profit		-$470.7K	-$1.236M
YoY Change		-61.92%	142.35%
Interest Expense		-$26.22K	$7.704K
YoY Change		-440.34%	-92.45%
% of Operating Profit
Other Income/Expense, Net		-$26.17K	$64.90K
YoY Change		-140.32%	-167.34%
Pretax Income		-$496.8K	-$1.171M
YoY Change		-57.58%	93.13%
Income Tax
% Of Pretax Income
Net Earnings		-$496.8K	-$1.171M
YoY Change		-57.58%	93.13%
Net Earnings / Revenue		-35112.23%	-101755.26%
Basic Earnings Per Share		$0.00	-$0.01
Diluted Earnings Per Share		$0.00	-$0.01
COMMON SHARES
Basic Shares Outstanding	159.7M shares	159.7M shares	157.2M shares
Diluted Shares Outstanding		159.7M shares	156.1M shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$720.00	$1.660K
YoY Change	-56.63%
Cash & Equivalents	$717.00	$1.660K
Short-Term Investments
Other Short-Term Assets	$200.00	$200.00
YoY Change	0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables	$5.126K	$9.093K
Total Short-Term Assets	$5.843K	$10.75K
YoY Change	-45.66%	-95.31%
LONG-TERM ASSETS
Property, Plant & Equipment		$39.13K
YoY Change		-17.04%
Goodwill
YoY Change
Intangibles	$1.115M	$1.191M
YoY Change	-6.32%	3989.38%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.115M	$1.230M
YoY Change	-9.3%	6.06%
TOTAL ASSETS
Total Short-Term Assets	$5.843K	$10.75K
Total Long-Term Assets	$1.115M	$1.230M
Total Assets	$1.121M	$1.241M
YoY Change	-9.62%	-10.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$400.3K	$293.2K
YoY Change	36.49%	179.16%
Accrued Expenses	$1.615M	$1.317M
YoY Change	22.63%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$826.7K
YoY Change	-100.0%
Total Short-Term Liabilities	$2.015M	$2.437M
YoY Change	-17.3%	-15.83%
LONG-TERM LIABILITIES
Long-Term Debt	$970.4K	$532.8K
YoY Change	82.14%
Other Long-Term Liabilities	$45.54K	$83.50K
YoY Change	-45.46%
Total Long-Term Liabilities	$1.016M	$616.3K
YoY Change	64.85%	-21.3%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.015M	$2.437M
Total Long-Term Liabilities	$1.016M	$616.3K
Total Liabilities	$3.031M	$3.053M
YoY Change	-0.72%	-16.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$17.31M	-$16.07M
YoY Change	7.72%	29.35%
Common Stock	$1.597M	$1.572M
YoY Change	1.58%	-0.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.910M	-$1.812M
YoY Change
Total Liabilities & Shareholders Equity	$1.121M	$1.241M
YoY Change	-9.62%	-10.68%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	-$496.8K	-$1.171M
YoY Change	-57.58%	93.13%
Depreciation, Depletion And Amortization	$1.179K	$176.8K
YoY Change	-99.33%
Cash From Operating Activities	-$83.00K	-$412.6K
YoY Change	-79.88%
INVESTING ACTIVITIES
Capital Expenditures	$2.060K	$21.94K
YoY Change	-90.61%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities	-$2.060K	-$21.94K
YoY Change	-90.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	85.09K	383.0K
YoY Change	-77.78%
NET CHANGE
Cash From Operating Activities	-83.00K	-412.6K
Cash From Investing Activities	-2.060K	-21.94K
Cash From Financing Activities	85.09K	383.0K
Net Change In Cash	30.00	-51.57K
YoY Change	-100.06%
FREE CASH FLOW
Cash From Operating Activities	-$83.00K	-$412.6K
Capital Expenditures	$2.060K	$21.94K
Free Cash Flow	-$85.06K	-$434.5K
YoY Change	-80.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-2355916
	dei	Entity Address Address Line1 EntityAddressAddressLine1	30 N. Gould St.
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-260902
	dei	Entity Registrant Name EntityRegistrantName	Bubblr, Inc.
CY2024Q3	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Annual Forfeiture ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeiture	0.13	pure
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	157690447	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	157690447	shares
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	588000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13052000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	12464000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y7M9D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y7M9D
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	292044	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1450608	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1450608	usd
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	74074	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	472198	usd
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	74074	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	472198	usd
CY2024Q3	BBLR	Unrecognized Compensation Liability Current UnrecognizedCompensationLiabilityCurrent	95403	usd
CY2024Q3	BBLR	Unrecognized Compensation Liability Current UnrecognizedCompensationLiabilityCurrent	95403	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001873722
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax		usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax		usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax		usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	BBLR	Forfeit Of Restricted Stock Units ForfeitOfRestrictedStockUnits		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	BBLR	Proceeds From Sale Of Fixed Assets ProceedsFromSaleOfFixedAssets		usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax		usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax		usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax		usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	BBLR	Forfeit Of Restricted Stock Units ForfeitOfRestrictedStockUnits		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	BBLR	Proceeds From Sale Of Fixed Assets ProceedsFromSaleOfFixedAssets		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024Q3	BBLR	Research And Development Other Receivables ResearchAndDevelopmentOtherReceivables		usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2024Q3	BBLR	Loan Payable Related Party Current LoanPayableRelatedPartyCurrent		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024Q3	BBLR	Loan Payable Related Party Current LoanPayableRelatedPartyCurrent		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
	BBLR	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	BBLR	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WY
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	159690447	shares
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.01
CY2024Q3	us-gaap	Cash Cash	717	usd
CY2023Q4	us-gaap	Cash Cash	7668	usd
CY2024Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	5126	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	87503	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	5843	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	95171	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31302	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1115410	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1456628	usd
CY2024Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	1115410	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1487930	usd
CY2024Q3	us-gaap	Assets Assets	1121253	usd
CY2023Q4	us-gaap	Assets Assets	1583101	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	400262	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	373606	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1614860	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	943007	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2015122	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1487471	usd
CY2024Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	970391	usd
CY2024Q3	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement	45541	usd
CY2023Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement	39116	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1015932	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	591755	usd
CY2024Q3	us-gaap	Liabilities Liabilities	3031054	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2079226	usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
	BBLR	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ste R
	dei	Entity Address City Or Town EntityAddressCityOrTown	Sheridan
	dei	Entity Address State Or Province EntityAddressStateOrProvince	WY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	82801
	dei	City Area Code CityAreaCode	(646)
	dei	Local Phone Number LocalPhoneNumber	814-7184
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	159690447	shares
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.01
CY2024Q3	us-gaap	Cash Cash	717	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	5843	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	95171	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31302	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1456628	usd
CY2024Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	1115410	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1487930	usd
CY2024Q3	us-gaap	Assets Assets	1121253	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	400262	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	373606	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1614860	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	943007	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2015122	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1487471	usd
CY2024Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	970391	usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	552639	usd
CY2024Q3	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement	45541	usd
CY2023Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement	39116	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1015932	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	591755	usd
CY2024Q3	us-gaap	Liabilities Liabilities	3031054	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2079226	usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	159690447	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	159690447	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	159690447	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	159690447	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	159690447	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	159690447	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	1596904	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1596904	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13460969	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13168915	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17310000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15612775	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	342325	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	350830	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-1909801	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-496125	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1121253	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1583101	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1415	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1151	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4087	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1151	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	140	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1151	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	1275	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	1151	usd
	us-gaap	Gross Profit GrossProfit	2936	usd
	us-gaap	Gross Profit GrossProfit	1151	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	313869	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1016034	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	945538	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2211310	usd
CY2024Q3	us-gaap	Professional Fees ProfessionalFees	18228	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	13878	usd
	us-gaap	Professional Fees ProfessionalFees	71281	usd
	us-gaap	Professional Fees ProfessionalFees	178612	usd
CY2024Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	26721	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	93125	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	38666	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	511141	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	59238	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	54331	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	420372	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	176840	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	53886	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	59889	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	151524	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	151160	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	471942	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1237257	usd
	us-gaap	Operating Expenses OperatingExpenses	1627381	usd
	us-gaap	Operating Expenses OperatingExpenses	3229063	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-470667	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1236106	usd
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	1596904	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1596904	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13460969	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13168915	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15612775	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	350830	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-1909801	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-496125	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1121253	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1583101	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1415	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1151	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1151	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	140	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1151	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	1275	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	1151	usd
	us-gaap	Gross Profit GrossProfit	2936	usd
	us-gaap	Gross Profit GrossProfit	1151	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	313869	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1016034	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	945538	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2211310	usd
CY2024Q3	us-gaap	Professional Fees ProfessionalFees	18228	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	13878	usd
	us-gaap	Professional Fees ProfessionalFees	178612	usd
CY2024Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	26721	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	93125	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	38666	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	511141	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	420372	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	176840	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	53886	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	59889	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	151524	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	471942	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1237257	usd
	us-gaap	Operating Expenses OperatingExpenses	1627381	usd
	us-gaap	Operating Expenses OperatingExpenses	3229063	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-470667	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1236106	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1624445	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3227912	usd
CY2024Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	135	usd
CY2023Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	29	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	14182	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	142	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	77	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	6196	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	9450	usd
CY2024Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-89	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-9420	usd
CY2024Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-26226	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1624445	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3227912	usd
CY2024Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	135	usd
CY2023Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	29	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	14182	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	142	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	77	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	7704	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	6196	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	9450	usd
CY2024Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-26226	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	114714	usd
CY2024Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	86	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-44667	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	98	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-6250	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-26171	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	65173	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7761	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	99156	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-496838	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1170933	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1632206	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3128756	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-496838	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1170933	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1632206	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3128756	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	68986	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	9325	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	68986	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	9325	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-496838	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1101947	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1632206	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3119431	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	159660447	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	159660447	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	159690447	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	159690447	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156271697	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	156271697	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	86277	usd
CY2023	BBLR	Stock Issued During Period Value Issuance Of Common Shares For Investor Relations StockIssuedDuringPeriodValueIssuanceOfCommonSharesForInvestorRelations	285338	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100000	usd
CY2023	BBLR	Stock Issued During Period Value Issued For Professional Services StockIssuedDuringPeriodValueIssuedForProfessionalServices	65000	usd
CY2023Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	117515	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-6425	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	114714	usd
CY2024Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	86	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-44667	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	98	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-6250	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-26171	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7761	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	99156	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-496838	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1170933	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1632206	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3128756	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-496838	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1170933	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1632206	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3128756	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	68986	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	9325	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	68986	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-496838	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1101947	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1632206	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3119431	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	159660447	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	159660447	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	86277	usd
CY2023	BBLR	Stock Issued During Period Value Issuance Of Common Shares For Investor Relations StockIssuedDuringPeriodValueIssuanceOfCommonSharesForInvestorRelations	285338	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100000	usd
CY2023	BBLR	Stock Issued During Period Value Issued For Professional Services StockIssuedDuringPeriodValueIssuedForProfessionalServices	65000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	43805	usd
CY2023	BBLR	Stock Issued During Period Value Loan Resolution StockIssuedDuringPeriodValueLoanResolution	821431	usd
CY2023	BBLR	Stock Issued During Period Value Forfeit Restrictive Stock Units StockIssuedDuringPeriodValueForfeitRestrictiveStockUnits	-659052	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	1559597	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2650650	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-61183	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-496125	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-496125	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1632206	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-12101	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-1909801	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-1909801	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1632206	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3128756	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	450338	usd
	BBLR	Forfeit Of Restricted Stock Units ForfeitOfRestrictedStockUnits	-659052	usd
	BBLR	Vesting Of Deferred Stock Based Compensation VestingOfDeferredStockBasedCompensation	-292054	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	43805	usd
CY2023	BBLR	Stock Issued During Period Value Loan Resolution StockIssuedDuringPeriodValueLoanResolution	821431	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	1559597	usd
CY2023	BBLR	Stock Issued During Period Value Preferred Shares Dividend StockIssuedDuringPeriodValuePreferredSharesDividend	-86688	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2650650	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-61183	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-496125	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-496125	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	292054	usd
	BBLR	Stock Issued During Period Value Preferred Shares Dividend StockIssuedDuringPeriodValuePreferredSharesDividend	-65019	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1632206	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-12101	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-1909801	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-1909801	usd
	BBLR	Vesting Of Deferred Stock Based Compensation VestingOfDeferredStockBasedCompensation	-292054	usd
	BBLR	Vesting Of Deferred Stock Based Compensation VestingOfDeferredStockBasedCompensation	-1450608	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-6425	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	114984	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-9420	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6954	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	415467	usd
	us-gaap	Depreciation Depreciation	9210	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-887	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	14620	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	216666	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	588361	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1187896	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-214009	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-412603	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	21935	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21935	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	12652	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	7467	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	28992	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	18228	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	245977	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	408665	usd
	BBLR	Proceeds From Sale Of Fixed Assets ProceedsFromSaleOfFixedAssets	17077	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	221410	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	382970	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-380	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20695	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6951	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7668	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	32533	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	717	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1660	usd
	us-gaap	Interest Paid Net InterestPaidNet	8471	usd
	us-gaap	Interest Paid Net InterestPaidNet	12921	usd
	BBLR	Declared Dividends DeclaredDividends	65018	usd
	BBLR	Declared Dividends DeclaredDividends	43805	usd
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2019-10-22
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1632206	usd
	BBLR	Vesting Of Deferred Stock Based Compensation VestingOfDeferredStockBasedCompensation	-1450608	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-6425	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	114984	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-9420	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6954	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	415467	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	167630	usd
	us-gaap	Depreciation Depreciation	4905	usd
	us-gaap	Depreciation Depreciation	9210	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-86945	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-887	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	14620	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	216666	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	588361	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1187896	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-214009	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-412603	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	13972	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	21935	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13972	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21935	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	12652	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	28992	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	18228	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	245977	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	408665	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	221410	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-380	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20695	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6951	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-30873	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7668	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	32533	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	717	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1660	usd
	us-gaap	Interest Paid Net InterestPaidNet	8471	usd
	us-gaap	Interest Paid Net InterestPaidNet	12921	usd
	BBLR	Declared Dividends DeclaredDividends	65018	usd
	BBLR	Declared Dividends DeclaredDividends	43805	usd
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2019-10-22
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1632206	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17310000	usd
CY2024Q3	BBLR	Working Capital WorkingCapital	2009279	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17310000	usd
CY2024Q3	BBLR	Working Capital WorkingCapital	2009279	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zwZ6SGwlEbo3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparing consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclose contingent assets and liabilities at the date of the financial statements, and report the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex; consequently, results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4087	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1151	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1415	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1151	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4087	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1151	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1415	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1151	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1115410	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1449049	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1115410	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1449049	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zwZ6SGwlEbo3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparing consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclose contingent assets and liabilities at the date of the financial statements, and report the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex; consequently, results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4087	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1151	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1415	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1151	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4087	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1151	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1415	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1151	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1115410	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1449049	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1115410	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1449049	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2023	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	6367	usd
CY2024Q3	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement	45541	usd
CY2023Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement	39116	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2023	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	6367	usd
CY2024Q3	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement	45541	usd
CY2023Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement	39116	usd
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_847_eus-gaap--DerivativesReportingOfDerivativeActivity_zbXME1dkhyF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common Stock Purchase Warrants and Derivative Financial Instruments</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses the classification of its common stock purchase warrants and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5742236	shares
CY2024Q3	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	1.3374	pure
CY2023Q3	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	1.2199	pure
CY2023Q4	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	1.2731	pure
CY2024Q3	us-gaap	Derivative Average Forward Exchange Rate1 DerivativeAverageForwardExchangeRate1	1.2772	pure
CY2023Q3	us-gaap	Derivative Average Forward Exchange Rate1 DerivativeAverageForwardExchangeRate1	1.2447	pure
CY2023Q4	us-gaap	Derivative Average Forward Exchange Rate1 DerivativeAverageForwardExchangeRate1	1.2441	pure
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_847_eus-gaap--DerivativesReportingOfDerivativeActivity_zbXME1dkhyF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common Stock Purchase Warrants and Derivative Financial Instruments</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses the classification of its common stock purchase warrants and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5742236	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5742236	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5742236	shares
	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	9	usd
	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	44667	usd
CY2024Q3	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	1.3374	pure
CY2023Q3	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	1.2199	pure
CY2024Q3	us-gaap	Derivative Average Forward Exchange Rate1 DerivativeAverageForwardExchangeRate1	1.2772	pure
CY2023Q3	us-gaap	Derivative Average Forward Exchange Rate1 DerivativeAverageForwardExchangeRate1	1.2447	pure
CY2023Q4	us-gaap	Derivative Average Forward Exchange Rate1 DerivativeAverageForwardExchangeRate1	1.2441	pure
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_847_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zTvS4pLKd3ef" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reclassifications</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain accounts have been reclassified in prior periods to conform to the current period presentation. Compensation expenses that were previously reported separately have been combined with general and administrative expenses in the Consolidated Statements of Operations and Comprehensive Loss for all periods presented.</span></p>
CY2024Q3	us-gaap	Deposit Assets DepositAssets	200	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	200	usd
CY2023Q4	BBLR	Research And Development Other Receivables ResearchAndDevelopmentOtherReceivables	80205	usd
CY2023Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	7098	usd
CY2024Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	5126	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	17139	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17139	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	58180	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31302	usd
	us-gaap	Depreciation Depreciation	9210	usd
CY2024Q3	us-gaap	Depreciation Depreciation	1179	usd
CY2023Q3	us-gaap	Depreciation Depreciation	2826	usd
CY2024Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	9420	usd
CY2023Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	9420	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_847_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zTvS4pLKd3ef" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reclassifications</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain accounts have been reclassified in prior periods to conform to the current period presentation. Compensation expenses that were previously reported separately have been combined with general and administrative expenses in the Consolidated Statements of Operations and Comprehensive Loss for all periods presented.</span></p>
CY2024Q3	us-gaap	Deposit Assets DepositAssets	200	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	200	usd
CY2023Q4	BBLR	Research And Development Other Receivables ResearchAndDevelopmentOtherReceivables	80205	usd
CY2024Q3	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	4926	usd
CY2023Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	7098	usd
CY2024Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	5126	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	87503	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	17139	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	89482	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17139	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	58180	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31302	usd
	us-gaap	Depreciation Depreciation	9210	usd
CY2024Q3	us-gaap	Depreciation Depreciation	1179	usd
CY2023Q3	us-gaap	Depreciation Depreciation	2826	usd
CY2024Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	9420	usd
CY2023Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	9420	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3604970	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1456628	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	415467	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	167630	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	188856	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	51505	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3604970	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3419922	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2489560	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1963294	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1115410	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1456628	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	415467	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	167630	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	188856	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	51505	usd
CY2024Q3	BBLR	Director Fees DirectorFees	211000	usd
CY2023Q4	BBLR	Director Fees DirectorFees	90000	usd
CY2024Q3	BBLR	Dividends Payable DividendsPayable	130032	usd
CY2023Q4	BBLR	Dividends Payable DividendsPayable	65016	usd
CY2024Q3	BBLR	Other Accred Liabilities OtherAccredLiabilities	60010	usd
CY2023Q4	BBLR	Other Accred Liabilities OtherAccredLiabilities	76945	usd
CY2024Q3	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	166986	usd
CY2023Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	166986	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1046832	usd
CY2024Q3	BBLR	Director Fees DirectorFees	211000	usd
CY2023Q4	BBLR	Director Fees DirectorFees	90000	usd
CY2023Q4	BBLR	Dividends Payable DividendsPayable	65016	usd
CY2024Q3	BBLR	Other Accred Liabilities OtherAccredLiabilities	60010	usd
CY2024Q3	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	166986	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1046832	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	544060	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1614860	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	943007	usd
CY2023Q4	BBLR	Loan Payable Related Party Non Current LoanPayableRelatedPartyNonCurrent	552639	usd
CY2024Q3	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	5000000	usd
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	434089
CY2024Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	549079	usd
CY2022Q3	BBLR	Derivative Loss On Contract DerivativeLossOnContract	28043	usd
CY2022Q3	us-gaap	Gain Loss On Securitization Of Financial Assets GainLossOnSecuritizationOfFinancialAssets	95768	usd
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	43805	usd
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	159690447	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	159690447	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	159690447	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	159690447	shares
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	544060	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1614860	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	943007	usd
CY2023Q4	BBLR	Loan Payable Related Party Current LoanPayableRelatedPartyCurrent	158248	usd
CY2024Q3	BBLR	Loan Payable Related Party Non Current LoanPayableRelatedPartyNonCurrent	970391	usd
CY2023Q4	BBLR	Loan Payable Related Party Non Current LoanPayableRelatedPartyNonCurrent	552639	usd
CY2024Q3	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	5000000	usd
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	434089
CY2024Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	549079	usd
CY2022Q3	us-gaap	Gain Loss On Securitization Of Financial Assets GainLossOnSecuritizationOfFinancialAssets	95768	usd
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2023	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	43805	usd
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	159690447	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	159690447	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	159690447	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	2538101	shares
CY2023Q4	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.32
CY2023	BBLR	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y2M23D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	2538101	shares
CY2024Q3	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.32
	BBLR	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y5M23D
CY2024Q3	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	2538101	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	2538101	shares
CY2023Q4	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.32
CY2023	BBLR	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y2M23D
CY2024Q3	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.32
	BBLR	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y5M23D
CY2024Q3	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	2538101	shares
CY2024Q3	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice	0.32
	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Exercisable Weighted Average Remaining Contractual Term1 ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingExercisableWeightedAverageRemainingContractualTerm1	P2Y5M23D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	2538101	shares
	BBLR	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm	P2Y5M23D
CY2024Q3	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.32
CY2023Q2	BBLR	Option Vest Description OptionVestDescription	Company granted executives, management, and a non-executive director options to purchase our common stock as compensation for time served. The Board of Directors determines the terms of the stock option grants, which are consistent with our 2022 Equity Incentive Plan.
CY2023Q2	BBLR	Option Grant Description OptionGrantDescription	Our stock option grant general policy is that options vest 40% after 90 days of service, and the remaining options vest monthly over two years. The maximum term is ten years.
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14400000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.1560
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	500000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.0239
	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	1848000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0.0030
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13052000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.1769
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	12464000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.210
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	4368000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	500000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	1848000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	2432000	shares
CY2024Q3	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice	0.32
	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Exercisable Weighted Average Remaining Contractual Term1 ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingExercisableWeightedAverageRemainingContractualTerm1	P2Y5M23D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	2538101	shares
	BBLR	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm	P2Y5M23D
CY2024Q3	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.32
CY2024Q3	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber	2538101	shares
CY2024Q3	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice	0.32
CY2023Q2	BBLR	Option Vest Description OptionVestDescription	Company granted executives, management, and a non-executive director options to purchase our common stock as compensation for time served. The Board of Directors determines the terms of the stock option grants, which are consistent with our 2022 Equity Incentive Plan.
CY2023Q2	BBLR	Option Grant Description OptionGrantDescription	Our stock option grant general policy is that options vest 40% after 90 days of service, and the remaining options vest monthly over two years. The maximum term is ten years.
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14400000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.1560
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	500000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.0239
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13052000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.1769
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	12464000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.210
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0435	pure
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	500000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	1848000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	2432000	shares
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	588000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13052000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	12464000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y7M9D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y7M9D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.1776
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	292044	usd

Files In Submission

Name	View Source	Status
0001493152-24-045296-index-headers.html	Edgar Link	pending
0001493152-24-045296-index.html	Edgar Link	pending
0001493152-24-045296.txt	Edgar Link	pending
0001493152-24-045296-xbrl.zip	Edgar Link	pending
bblr-20240930.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
logo_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
bblr-20240930_cal.xml	Edgar Link	unprocessable
bblr-20240930_def.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bblr-20240930_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bblr-20240930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BBLR
Bubblr Inc. Stock $bblr

2024 Q4 Form 10-Q Financial Statement

#000149315224045296 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BBLR Bubblr Inc. Stock $bblr

2024 Q4 Form 10-Q Financial Statement

#000149315224045296 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BBLR
Bubblr Inc. Stock $bblr